Stock MDP MEDEXUS PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Medexus Pharmaceuticals Inc.

Equities

MDP

CA58410Q2036

Delayed Toronto S.E.
Other stock markets
 09:30:24 2024-06-03 am EDT 		5-day change 1st Jan Change
1.65 CAD +1.85% Intraday chart for Medexus Pharmaceuticals Inc. +1.85% -33.20%
Mar. 26 Medexus Pharmaceuticals Announces US Food and Drug Administration Approves It's Supplemental Biologics License Application for IXINITY(R) CI
Feb. 09 Medexus Pharmaceuticals Maintained at Speculative Buy at Stifel GMP After Fiscal Q3 Miss; Price Target Cut to C$2.85 MT

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Medexus Pharmaceuticals Maintained at Speculative Buy at Stifel GMP After Fiscal Q3 Miss; Price Target Cut to C$2.85
MT
Medexus Pharmaceuticals Buy Rating Maintained by Stifel GMP as Drug Approvals Awaited; Price Target Lowered to C$11.00
MT
Medexus Pharmaceuticals Initiated at Outperform With $5.50 Target at Raymond James
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MDP Stock
  4. News Medexus Pharmaceuticals Inc.
  5. Analyst Reco.